129 related articles for article (PubMed ID: 21073335)
1. Regulation of bone mass by serotonin: molecular biology and therapeutic implications.
Karsenty G; Yadav VK
Annu Rev Med; 2011; 62():323-31. PubMed ID: 21073335
[TBL] [Abstract][Full Text] [Related]
2. [Intestinal serotonin and regulation of bone mass].
Oury F; Karsenty G
Med Sci (Paris); 2009 May; 25(5):445-6. PubMed ID: 19480820
[No Abstract] [Full Text] [Related]
3. Efficacy of serotonin inhibition in mouse models of bone loss.
Inose H; Zhou B; Yadav VK; Guo XE; Karsenty G; Ducy P
J Bone Miner Res; 2011 Sep; 26(9):2002-11. PubMed ID: 21608033
[TBL] [Abstract][Full Text] [Related]
4. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.
Yadav VK; Balaji S; Suresh PS; Liu XS; Lu X; Li Z; Guo XE; Mann JJ; Balapure AK; Gershon MD; Medhamurthy R; Vidal M; Karsenty G; Ducy P
Nat Med; 2010 Mar; 16(3):308-12. PubMed ID: 20139991
[TBL] [Abstract][Full Text] [Related]
6. Lrp5 and bone formation : A serotonin-dependent pathway.
Yadav VK; Ducy P
Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of Lrp5 function in osteoblast progenitors.
Yadav VK; Arantes HP; Barros ER; Lazaretti-Castro M; Ducy P
Calcif Tissue Int; 2010 May; 86(5):382-8. PubMed ID: 20333369
[TBL] [Abstract][Full Text] [Related]
8. [Control of bone remodeling by nervous system. The role of serotonin in the regulation of bone metabolism].
Inose H
Clin Calcium; 2010 Dec; 20(12):1850-956. PubMed ID: 21123937
[TBL] [Abstract][Full Text] [Related]
9. [The pathophysiology of osteoporosis/osteopenia in gene mutant mice].
Kobayashi Y; Takahashi N
Clin Calcium; 2006 Feb; 16(2):311-18. PubMed ID: 16465035
[TBL] [Abstract][Full Text] [Related]
10. [Serotonin, two faces of a unique molecule in the regulation of bone mass].
Oury F; Karsenty G
Med Sci (Paris); 2010; 26(8-9):713-8. PubMed ID: 20819707
[TBL] [Abstract][Full Text] [Related]
11. New approaches to the treatment of osteoporosis.
Silva BC; Bilezikian JP
Annu Rev Med; 2011; 62():307-22. PubMed ID: 21054170
[TBL] [Abstract][Full Text] [Related]
12. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin.
Frost M; Andersen TE; Yadav V; Brixen K; Karsenty G; Kassem M
J Bone Miner Res; 2010 Mar; 25(3):673-5. PubMed ID: 20200960
[TBL] [Abstract][Full Text] [Related]
13. The two faces of serotonin in bone biology.
Ducy P; Karsenty G
J Cell Biol; 2010 Oct; 191(1):7-13. PubMed ID: 20921133
[TBL] [Abstract][Full Text] [Related]
14. LP533401 restores bone health in 5/6 nephrectomized rats by a decrease of gut-derived serotonin and regulation of serum phosphate through the inhibition of phosphate co-transporters expression in the kidneys.
Pawlak D; Znorko B; Kalaska B; Domaniewski T; Zawadzki R; Lipowicz P; Doroszko M; Łebkowska U; Grabowski P; Pawlak K
Bone; 2018 Aug; 113():124-136. PubMed ID: 29792935
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.
Hartikka H; Mäkitie O; Männikkö M; Doria AS; Daneman A; Cole WG; Ala-Kokko L; Sochett EB
J Bone Miner Res; 2005 May; 20(5):783-9. PubMed ID: 15824851
[TBL] [Abstract][Full Text] [Related]
16. Serotonin rising--the bone, brain, bowel connection.
Rosen CJ
N Engl J Med; 2009 Mar; 360(10):957-9. PubMed ID: 19264685
[No Abstract] [Full Text] [Related]
17. When the gut talks to bone.
Long F
Cell; 2008 Nov; 135(5):795-6. PubMed ID: 19041744
[TBL] [Abstract][Full Text] [Related]
18. Rebuilding Humpty Dumpty with a serotonin inhibitor.
Seeman E
Nat Med; 2010 Mar; 16(3):264-5. PubMed ID: 20208508
[No Abstract] [Full Text] [Related]
19. Fractures are not in genes.
Kannus P; Järvinen T; Sievänen H; Khan K
Lancet; 2008 Oct; 372(9648):1459-60; author reply 1460. PubMed ID: 18970970
[No Abstract] [Full Text] [Related]
20. Antidepressant effect of a tryptophan hydroxylase activation inhibitor, AGN 2979.
Clerc G; Noury J; Gittos M
Am J Psychiatry; 1986 Feb; 143(2):264-5. PubMed ID: 3511742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
